Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
Authors
Keywords
-
Journal
PROSTATE
Volume 72, Issue 15, Pages 1611-1621
Publisher
Wiley
Online
2012-03-16
DOI
10.1002/pros.22514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluación del test PCA3 para el diagnóstico de cáncer de próstata: revisión sistemática y metanálisis
- (2013) J. Ruiz-Aragón et al. Actas Urologicas Espanolas
- GC/MS-based metabolomic approach to validate the role of urinary sarcosine and target biomarkers for human prostate cancer by microwave-assisted derivatization
- (2011) Hao Wu et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
- (2011) Marco Auprich et al. EUROPEAN UROLOGY
- Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer
- (2011) Samir M. Hanash et al. Nature Reviews Clinical Oncology
- Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine
- (2011) D-L Cao et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Application of metabolomics to prostate cancer
- (2011) Bruce J. Trock UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness
- (2010) L. J. Sokoll et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12–8
- (2010) Arun Sreekumar et al. EUROPEAN UROLOGY
- Re: Florian Jentzmik, Carsten Stephan, Kurt Miller, et al. Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours. Eur Urol 2010;58:12–8
- (2010) Daniela Colleselli et al. EUROPEAN UROLOGY
- Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours
- (2010) Florian Jentzmik et al. EUROPEAN UROLOGY
- Clinical Implications of TMPRSS2-ERG Gene Fusion Expression in Patients With Prostate Cancer Treated With Radical Prostatectomy
- (2010) José Rubio-Briones et al. JOURNAL OF UROLOGY
- Sarcosine in Prostate Cancer Tissue is Not a Differential Metabolite for Prostate Cancer Aggressiveness and Biochemical Progression
- (2010) Florian Jentzmik et al. JOURNAL OF UROLOGY
- TMPRSS2–ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
- (2010) Samson W Fine et al. MODERN PATHOLOGY
- Urine biomarkers in prostate cancer
- (2010) Guillaume Ploussard et al. Nature Reviews Urology
- Blood and Tissue Biomarkers in Prostate Cancer: State of the Art
- (2010) Michelangelo Fiorentino et al. UROLOGIC CLINICS OF NORTH AMERICA
- Serum sarcosine is not a marker for prostate cancer
- (2010) E. A. Struys et al. ANNALS OF CLINICAL BIOCHEMISTRY
- TMPRSS2:ERGfusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis
- (2009) KARI ROSTAD et al. APMIS
- TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
- (2009) Anuradha Gopalan et al. CANCER RESEARCH
- Clinical Applications of Metabolomics in Oncology: A Review
- (2009) J. L. Spratlin et al. CLINICAL CANCER RESEARCH
- Biomarkers in prostate cancer diagnosis and prognosis: beyond prostate-specific antigen
- (2009) Yves Fradet CURRENT OPINION IN UROLOGY
- A Risk-Based Strategy Improves Prostate-Specific Antigen–Driven Detection of Prostate Cancer
- (2009) Monique J. Roobol et al. EUROPEAN UROLOGY
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
- (2008) O. R. Saramaki et al. CLINICAL CANCER RESEARCH
- Emerging Biomarkers for the Diagnosis and Prognosis of Prostate Cancer
- (2008) G. Sardana et al. CLINICAL CHEMISTRY
- Detection of Bladder Cancer in Human Urine by Metabolomic Profiling Using High Performance Liquid Chromatography/Mass Spectrometry
- (2008) Haleem J. Issaq et al. JOURNAL OF UROLOGY
- [-2]Proenzyme Prostate Specific Antigen for Prostate Cancer Detection: A National Cancer Institute Early Detection Research Network Validation Study
- (2008) Lori J. Sokoll et al. JOURNAL OF UROLOGY
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
- Urine Metabolomics Analysis for Kidney Cancer Detection and Biomarker Discovery
- (2008) Kyoungmi Kim et al. MOLECULAR & CELLULAR PROTEOMICS
- A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases
- (2008) Carsten Stephan et al. PROSTATE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started